Here's Why Ziopharm Oncology Stock Is Up 18% This Week

115
4
Favorite

Here's Why Ziopharm Oncology Stock Is Up 18% This Week

Motley Fool2021-09-10

What happened Shares of Ziopharm Oncology (NASDAQ:ZIOP), jumped more than 30% on Tuesday. Shares of the clinical-stage biopharmaceutical company finished Thursday up around 18% from their closing ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

115

Report

Comment（4）

BarleyIce
·2021-09-10
K
Reply
2
Report
Fold Replies
- BarleyIce:
  Ok
  2021-09-10
  Reply
  Report
Timjoe
·2021-09-10
Like like
Reply
2
Report
RainnieC
·2021-09-10
Hit the like button pls！?
Reply
9
Report
Fold Replies
- AL30:
  Sure
  2021-09-10
  Reply
  Report
- JimmyT:
  ok
  2021-09-10
  Reply
  Report
HuatKueh313
·2021-09-10
Like pls
Reply
9
Report
Fold Replies
- HuatKueh313:
  thks
  2021-09-12
  Reply
  Report
- Liha:
  Wowwwww
  2021-09-10
  Reply
  Report
- EverSys:
  Ye
  2021-09-10
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2166373377?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-09-10 21:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2166373377","market":"us","top_or_hot":-1,"title":"Here's Why Ziopharm Oncology Stock Is Up 18% This Week","media":"Motley Fool","content":"<div>\n<p>What happened\nShares of Ziopharm Oncology (NASDAQ:ZIOP), jumped more than 30% on Tuesday. Shares of the clinical-stage biopharmaceutical company finished Thursday up around 18% from their closing ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/10/heres-why-ziopharm-stock-is-up-this-week/\">Source Link</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why Ziopharm Oncology Stock Is Up 18% This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why Ziopharm Oncology Stock Is Up 18% This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-10 21:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/10/heres-why-ziopharm-stock-is-up-this-week/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\nShares of Ziopharm Oncology (NASDAQ:ZIOP), jumped more than 30% on Tuesday. Shares of the clinical-stage biopharmaceutical company finished Thursday up around 18% from their closing ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/10/heres-why-ziopharm-stock-is-up-this-week/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://www.fool.com/investing/2021/09/10/heres-why-ziopharm-stock-is-up-this-week/","article_id":"2166373377","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2166373377","pubTimestamp":1631280120,"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"Recent insider stock purchases were more than a little encouraging.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"这就是Ziopharm肿瘤公司股票本周上涨18%的原因","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZIOP":0.9},"content_text":"What happened\nShares of Ziopharm Oncology (NASDAQ:ZIOP), jumped more than 30% on Tuesday. Shares of the clinical-stage biopharmaceutical company finished Thursday up around 18% from their closing price last Friday. While the company's been quiet, investors were highly encouraged by a handful of insider stock purchases.\nSo what\nLast Friday afternoon, just before Labor Day weekend, Ziopharm disclosed to the Securities and Exchange Commission four direct stock purchases from company insiders. James Huang, a financier of several lucrative life-science ventures including Legend Biotech, raised his stake from a little over 8,000 shares to around 108,000 shares. One of the company's largest shareholders, Robert Postma, bought 75,000 shares pushing his total Ziopharm holdings past 5.45 million shares.\n\nImage source: Getty Images.\nKevin Boyle, who became CEO in August, wasn't one of the insiders who disclosed a big purchase on Sept. 3. That's probably because the company gave him 875,000 shares when he was appointed to the lead role on Aug. 30.\nNow what\nInsiders also happen to be people with bills to pay and luxuries to acquire. Investors need to remember that insider selling can mean lots of things that are mostly innocuous. Direct purchases like these, though, generally don't happen unless insiders expect the price to rise.\nAt his former position as CEO of Kuur Therapeutics, Boyle led the company through a successful transformation that ended with a $185 million acquisition by Athenex this May. It looks like the board members who hired Boyle are confident about his ability to try Ziopharm around, too.\nThe company's CD19-directed cellular therapy candidate started a trial in Taiwan this March, but it's on pause while the company refines its manufacturing process. With a clinical-stage pipeline collecting dust at the moment, Boyle has his work cut out for him.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":881992754,"gmtCreate":1631284115778,"gmtModify":1676530519927,"author":{"id":"3562802954762393","authorId":"3562802954762393","name":"BarleyIce","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3562802954762393","authorIdStr":"3562802954762393"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/881992754","repostId":2166373377,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5821303,"gmtCreate":1631284120419,"gmtModify":1663233682537,"authorId":3562802954762393,"author":{"id":3562802954762393,"idStr":"3562802954762393","authorId":3562802954762393,"name":"BarleyIce","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":881992754,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"},{"id":881908559,"gmtCreate":1631283673971,"gmtModify":1676530519679,"author":{"id":"3559438972700266","authorId":"3559438972700266","name":"Timjoe","avatar":"https://static.tigerbbs.com/381bdc673d91899ab697655314c737c4","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3559438972700266","authorIdStr":"3559438972700266"},"htmlText":"Like like","listText":"Like like","text":"Like like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/881908559","repostId":2166373377,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":881037396,"gmtCreate":1631280951315,"gmtModify":1676530517583,"author":{"id":"4094332432138780","authorId":"4094332432138780","name":"RainnieC","avatar":"https://static.tigerbbs.com/cf3aed598fd853660a3a1e9ebe364fed","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4094332432138780","authorIdStr":"4094332432138780"},"htmlText":"Hit the like button pls！?","listText":"Hit the like button pls！?","text":"Hit the like button pls！?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/881037396","repostId":2166373377,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5820554,"gmtCreate":1631281453059,"gmtModify":1663233679446,"authorId":3568580406017469,"author":{"id":3568580406017469,"idStr":"3568580406017469","authorId":3568580406017469,"name":"AL30","avatar":"https://static.tigerbbs.com/8f77aca4dee7e85735912a4dff52ffc6","vip":1,"crmLevel":1,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":881037396,"type":1,"supId":0,"prevId":0,"content":"Sure","text":"Sure","html":"Sure"},{"id":5820536,"gmtCreate":1631281352769,"gmtModify":1663233678041,"authorId":3581661369298834,"author":{"id":3581661369298834,"idStr":"3581661369298834","authorId":3581661369298834,"name":"JimmyT","avatar":"https://static.tigerbbs.com/748bb288232d8c7092b92b303f282d6e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":881037396,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"EN"},{"id":881032309,"gmtCreate":1631280830401,"gmtModify":1676530517511,"author":{"id":"3565832091209909","authorId":"3565832091209909","name":"HuatKueh313","avatar":"https://static.itradeup.com/news/fb2a3aa1007fa02bcad27f2593b66592","vip":1,"crmLevel":5,"crmLevelSwitch":1,"idStr":"3565832091209909","authorIdStr":"3565832091209909"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/881032309","repostId":2166373377,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5836762,"gmtCreate":1631409488139,"gmtModify":1663233748148,"authorId":3565832091209909,"author":{"id":3565832091209909,"idStr":"3565832091209909","authorId":3565832091209909,"name":"HuatKueh313","avatar":"https://static.itradeup.com/news/fb2a3aa1007fa02bcad27f2593b66592","vip":1,"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":881032309,"type":1,"supId":5820433,"prevId":0,"content":"thks","text":"thks","html":"thks"},{"id":5820433,"gmtCreate":1631280934890,"gmtModify":1663233676339,"authorId":3580021038510346,"author":{"id":3580021038510346,"idStr":"3580021038510346","authorId":3580021038510346,"name":"Liha","avatar":"https://static.tigerbbs.com/a4ba484754a4e8fc7a7c54ab52161218","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":881032309,"type":1,"supId":0,"prevId":0,"content":"Wowwwww","text":"Wowwwww","html":"Wowwwww"},{"id":5820439,"gmtCreate":1631280976590,"gmtModify":1631891175513,"authorId":3562717829058854,"author":{"id":3562717829058854,"idStr":"3562717829058854","authorId":3562717829058854,"name":"EverSys","avatar":"https://static.tigerbbs.com/11a08d675c0a4f706a53d64244901417","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":881032309,"type":1,"supId":5820433,"prevId":0,"content":"Ye","text":"Ye","html":"Ye"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":115,"commentSize":4,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}